missing translation for 'onlineSavingsMsg'
Learn More

CTGF/CCN2 Antibody (CL5339) [DyLight 680], Novus Biologicals™

Mouse Monoclonal Antibody

Marke:  Novus Biologicals NBP2-61415FR

Artikelnummer. 30305604

  • 737.00 € / 0.10 Milliliter

om dit product te kopen Registreer vandaag om een webaccount aan te maken

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

CTGF/CCN2 Monoclonal antibody specifically detects CTGF/CCN2 in Human,Mouse,Rat samples. It is validated for Immunohistochemistry,Western Blot,Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Spezifikation

Spezifikation

CTGF/CCN2
Monoclonal
DyLight 680
CCN2IGFBP-8, connective tissue growth factor, HCS24, Hypertrophic chondrocyte-specific protein 24, IBP-8, IGF-binding protein 8, IGFBP8CCN family member 2, Insulin-like growth factor-binding protein 8, MGC102839, NOV2
This antibody was developed using a recombinant protein derived from P29279, with the exact immunogen sequence remaining proprietary.
0.1 mL
Angiogenesis, Cancer, Cell Biology, Cytokine Research, Growth and Development, Immunology, Innate Immunity
1490
Store at 4⪚C in the dark.
IgG1
Immunohistochemistry, Western Blot, Immunohistochemistry (Paraffin)
CL5339
50mM Sodium Borate
Mouse
Protein A purified
RUO
Primary
Human, Mouse, Rat
Purified
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.